Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Reumatol Clin (Engl Ed) ; 19(8): 412-416, 2023 Oct.
Article in English | MEDLINE | ID: mdl-37805254

ABSTRACT

OBJECTIVES: To study the prevalence of liver fibrosis (LF) measured by FibroScan and APRI index in patients with rheumatoid arthritis (AR) undergoing treatment with methotrexate (MTX). METHODS: We included 59 patients with RA on MTX. Medical records, FibroScan measures and serological markers of liver damage were compared on the basis of cumulative methotrexate dose. RESULTS: Mean treatment duration was 82.4±65.1 months and mean cumulative dose was 5214.5±4031.9mg. Five patients met LF criteria by fibroscan, while only one patient had a suggestive APRI score. No statistically significant differences were found in terms of LF measured by both APRI and fibroScan between patients with cumulative doses above and below 4000mg. There was also no relationship between LF and treatment duration. CONCLUSIONS: The occurrence of LF in patients with RA on MTX is a multifactorial process that does not seem directly related to its cumulative dose. FibroScan may be a useful technique in clinical practice to screen for this complication.


Subject(s)
Arthritis, Rheumatoid , Elasticity Imaging Techniques , Humans , Methotrexate/adverse effects , Arthritis, Rheumatoid/drug therapy , Arthritis, Rheumatoid/complications , Liver Cirrhosis/complications , Liver Cirrhosis/drug therapy , Elasticity Imaging Techniques/adverse effects , Elasticity Imaging Techniques/methods , Biomarkers
2.
Reumatol Clin (Engl Ed) ; 18(6): 374-376, 2022.
Article in English | MEDLINE | ID: mdl-35680367

ABSTRACT

Cardiac involvement in systemic sclerosis (SSc) is rare but leads to poor short-term prognosis. Evidence regarding heart transplantation (HT) is scarce and is based on experience with isolated cases. We present this case with the aim of analysing the characteristics of a patient with SS who has undergone a successful transplant.


Subject(s)
Heart Transplantation , Scleroderma, Systemic , Humans , Scleroderma, Systemic/complications , Scleroderma, Systemic/surgery
3.
Article in English, Spanish | MEDLINE | ID: mdl-34016550

ABSTRACT

Cardiac involvement in systemic sclerosis (SSc) is rare but leads to poor short-term prognosis. Evidence regarding heart transplantation (HT) is scarce and is based on experience with isolated cases. We present this case with the aim of analysing the characteristics of a patient with SS who has undergone a successful transplant.

SELECTION OF CITATIONS
SEARCH DETAIL
...